Development of Reference Control Material for the Evaluation of the Cepheid Prototype * Xpert® BCR-ABL P190 Ultra Assay

被引：0
|
作者：
Liu, Yuanyuan [1 ]
Tran Tran [1 ]
Phat Nguyen [1 ]
Wei, Huilin [1 ]
Day, Gwo-Jen [1 ]
Yuan, Lin [1 ]
机构：
[1] Cepheid, Oncol, R&D, Sunnyvale, CA USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-128856
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] New practice of BCR::ABL1 standardization system based on p210 and p190 BCR::ABL1 reference materials
    Ma, Yu
    Han, Yanxi
    Diao, Zhenli
    Chen, Yuqing
    Huang, Tao
    Feng, Lei
    Jiang, Jian
    Zhang, Yuanfeng
    Li, Jinming
    Zhang, Rui
    CLINICA CHIMICA ACTA, 2025, 565
  • [42] Validation of Cepheid® Xpert® BCR-ABL Monitor and Ultra assays used in the molecular monitoring of chronic myeloid leukaemia (CML) patients
    De Long, C.
    Swanepoel, C.
    Paul, L.
    Bassa, F.
    Grewal, R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 75 - 76
  • [43] Differential signaling through p190 and p210 BCR-ABL fusion proteins revealed by interactome and phosphoproteome analysis
    Cutler, J. A.
    Tahir, R.
    Sreenivasamurthy, S. K.
    Mitchell, C.
    Renuse, S.
    Nirujogi, R. S.
    Patil, A. H.
    Heydarian, M.
    Wong, X.
    Wu, X.
    Huang, T-C
    Kim, M-S
    Reddy, K. L.
    Pandey, A.
    LEUKEMIA, 2017, 31 (07) : 1513 - 1524
  • [44] Differential signaling networks of Bcr-Abl p210 and p190 kinases in leukemia cells defined by functional proteomics
    Reckel, S.
    Hamelin, R.
    Georgeon, S.
    Armand, F.
    Jolliet, Q.
    Chiappe, D.
    Moniatte, M.
    Hantschel, O.
    LEUKEMIA, 2017, 31 (07) : 1502 - 1512
  • [45] Differential signaling through p190 and p210 BCR-ABL fusion proteins revealed by interactome and phosphoproteome analysis
    J A Cutler
    R Tahir
    S K Sreenivasamurthy
    C Mitchell
    S Renuse
    R S Nirujogi
    A H Patil
    M Heydarian
    X Wong
    X Wu
    T-C Huang
    M-S Kim
    K L Reddy
    A Pandey
    Leukemia, 2017, 31 : 1513 - 1524
  • [46] Differential Signaling through p190 and p210 Forms of BCR-ABL Fusion Proteins Revealed By Proteomic Analysis
    Cutler, Jevon
    Tahir, Rahia
    Han, Jingnan
    Nirujogi, Raja Sekhar
    Huang, Tai-Chung
    Wong, Xianrong
    Mallampati, Saradhi
    Sun, Xiaoping
    Brown, Patrick
    Reddy, Karen
    Pandey, Akhilesh
    BLOOD, 2015, 126 (23)
  • [47] ESTABLISHMENT OF A LYMPHOBLASTOID CELL-LINE, SD-1, EXPRESSING THE P190 BCR-ABL CHIMERIC PROTEIN
    DHUT, S
    GIBBONS, B
    CHAPLIN, T
    YOUNG, BD
    LEUKEMIA, 1991, 5 (01) : 49 - 55
  • [48] P190 BCR-ABL mRNA is frequently expressed at a low level in p210 CML and p210 all
    vanRhee, F
    Hochhaus, A
    Lin, F
    Melo, JV
    Cross, NCP
    Goldman, JM
    BLOOD, 1995, 86 (10) : 2969 - 2969
  • [49] A Rare Case of p190 BCR-ABL Chronic Myeloid Leukemia With a Very Good Response to Tyrosine Kinase Inhibitors
    Gandhe, Nalinikumari
    Vekaria, Mona
    Dabak, Vrushali
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [50] P190(BCR-ABL) CHRONIC MYELOID-LEUKEMIA (CML) - THE MISSING LINK WITH CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
    MELO, JV
    MYINT, H
    GALTON, DAG
    GOLDMAN, JM
    BLOOD, 1993, 82 (10) : A554 - A554
12345